Cape Town, South Africa — December 1st, 2025 — Immobazyme, a South African platform biotechnology company building scalable, cost-effective biologics, has secured an additional R25 million in funding, bringing its total capital raised to R50 million. The round was led by the University Technology Fund (UTF II), with participation from Fireball Capital and University of Stellenbosch Enterprises (USE) as co-investors. The new capital will accelerate the expansion of Immobazyme’

The Growth Factor | Newsletter | April 2025 April Updates We were in high demand this month, with our team attending a range of exciting networking events - each celebrating innovation and entrepreneurship across South Africa’s biotech and startup landscape: The Annual CEO Function, hosted by the Innovus Technology Transfer Office at Stellenbosch University, brought together founders from Stellenbosch University’s startup ecosystem to celebrate the achievements and milestones

The Growth Factor | Newsletter | March 30th 2025 Ayanda Hlophe, Chemical Engineer, working in her lab. What’s happening in the labs? Immobazyme 🤝 Babylonstoren We’re proud to announce our collaboration with Babylonstoren, one of South Africa’s most iconic brands. Together with their team of food scientists, we’ve been working to identify the ideal starter cultures for their cured meat range. For our non-science friends: Starter cultures are preparations of beneficial microo

The Growth Factor | Newsletter | February 28, 2025 What's been brewing in the labs? New Product Drop: Recombinant Peptides We expanded our product lineup with two new recombinant peptides: sh-Oligopeptide-1 – A short-chain peptide known for its cell regeneration properties, making it a go-to ingredient in advanced skincare treatments. sh-Polypeptide-1 – A longer-chain peptide that supports tissue proliferation, with promising applications in treating alopecia. Scaling Up in J

From scaling production to global shipments, 2024 was a year of growth for Immobazyme. Read here for our latest milestones and what’s ahead!